Lazard Asset Management LLC Astrazeneca PLC Transaction History

Lazard Asset Management LLC

$58.2 Billion
Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,128,694 shares of AZN stock, worth $85 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,128,694

Previous 918,666 22.86%

Holding current value

$85 Million

Previous $60.2 Million 37.83%

% of portfolio

0.14%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $13.7 Million - $16.4 Million	210,028 Added 22.86%	1,128,694 $83 Million
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $15.3 Million - $19.3 Million	-242,203 Reduced 20.86%	918,666 $60.2 Million
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $58.3 Million - $66.6 Million	-759,767 Reduced 39.56%	1,160,869 $90.5 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $96.1 Million - $116 Million	1,437,904 Added 297.87%	1,920,636 $150 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $7.85 Million - $8.95 Million	128,616 Added 36.32%	482,732 $32.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $4.37 Million - $4.89 Million	70,557 Added 24.88%	354,116 $23.8 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $8.07 Million - $8.93 Million	124,513 Added 78.29%	283,559 $19.2 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $3.49 Million - $3.78 Million	49,908 Added 45.73%	159,046 $11.4 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $6.65 Million - $7.54 Million	105,276 Added 2725.95%	109,138 $7.57 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $26,779 - $34,797	494 Added 14.67%	3,862 $261,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $21,570 - $25,894	-364 Reduced 9.75%	3,368 $221,000
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $3.01 Million - $3.62 Million	-53,933 Reduced 93.53%	3,732 $246,000
Q4 2021 Feb 09, 2022	SELL	$54.02 - $63.83 $40.8 Million - $48.2 Million	-755,118 Reduced 92.91%	57,665 $3.36 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $35.4 Million - $38.7 Million	636,575 Added 361.26%	812,783 $48.8 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $8.51 Million - $10.6 Million	175,845 Added 48442.15%	176,208 $10.6 Million
Q2 2016 Jul 29, 2019	BUY	N/A	333 Added 1110.0%	363 $10,000
Q4 2015 Jul 24, 2019	BUY	N/A	30	30 $1,000

Others Institutions Holding AZN

# of Institutions

1,422

Shares Held

509M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Astrazeneca PLC Transaction History